iCan i3 Continuous Glucose Monitoring System
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for iCan i3 Continuous Glucose Monitoring System, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome [NA]